PCAT1 and colorectal carcinoma: In oxaliplatin-resistant CRC cells, reduced KLF4 expression weakens its transcriptional repression of PiHL, resulting in PiHL upregulation and activation of the EZH2/HMGA2/PI3K/Akt signaling pathway to promote oxaliplatin resistance (63).